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The PrP gene encodes the putative causative agent of the transmissible spongiform encepha-
lopathies (TSEs), a heterogeneous group of fatal, neurodegenerative disorders including human
Creutzfeldt–Jakob disease, bovine spongiform encephalopathy, ovine scrapie and chronic wasting
disease (CWD) of North American deer and elk. Polymorphisms in the PrP gene are associated with
variations in relative susceptibility, pathological lesion patterns, incubation times and clinical
course of TSEs of humans, mice and sheep. Sequence analysis of the PrP gene from Rocky Mountain
elk showed only one amino acid change (Met to Leu at cervid codon 132). Homozygosity for Met
at the corresponding polymorphic site (Met to Val) in humans (human codon 129) predisposes
exposed individuals to some forms of Creutzfeldt–Jakob disease. In this study, Rocky Mountain elk
homozygous for PrP codon 132 Met were over-represented in both free-ranging and farm-raised
CWD-affected elk when compared to unaffected control groups.
Introduction
Chronic wasting disease (CWD) is a transmissible spongi-
form encephalopathy (TSE) of captive and free-ranging elk
(Cervus elaphus nelsoni), mule deer (Odocoileus hemionus
hemionus) and white-tailed deer (O. virginianus) in a small area
of the western United States (Williams & Young, 1992 ; Spraker
et al., 1997). Clinical signs of CWD in elk include weight loss,
behavioural changes, polydipsia and polyuria, excessive sali-
vation and teeth grinding (Williams & Young, 1982). Patho-
logical changes in the central nervous system include spongi-
form encephalopathy and neuronal degeneration (Williams &
Young, 1993). CWD is a member of a heterogeneous group of
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The GenBank accession numbers for the sequences reported in this
paper are AF016227 (allele 132 M) and AF016228 (allele 132 L).
fatal, neurodegenerative disorders characterized by accumu-
lation of an abnormal isoform (PrP-Sc) of a cellular sialoglyo-
protein (PrP-C) (Bolton et al., 1982). PrP-Sc is a major
component of infectious tissue extracts and is thought to be
the transmissible agent, catalysing the conversion of PrP-C to
PrP-Sc in the susceptible host (Prusiner, 1982). TSEs occur
naturally in ruminant herbivores including sheep, goats, cattle,
deer and elk. TSEs of mink and cats occur rarely, possibly from
exposure to ruminant-derived infectious material (Marsh &
Bessen, 1993 ; Bradley & Wilesmith, 1991). The human TSEs
include a broad range of familial, sporadic and iatrogenic
diseases, notably Creutzfeldt–Jakob disease (CJD) and a new
variant of CJD (nvCJD) that probably originated from exposure
to TSE-contaminated bovine products (Hill et al., 1997 ; Bruce
et al., 1997).
Relative susceptibility to sporadic, iatrogenic and nvCJD is
associated with the primary sequence of the host PrP-C. A
nonpathogenic polymorphism at codon 129 of the human PrP
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gene encodes Met or Val. Homozygosity at codon 129
predisposes individuals to iatrogenic and sporadic CJD
(Collinge et al., 1991 ; Palmer et al., 1991). nvCJD has been
diagnosed to date only in 129 Met}Met homozygotes (Zeidler
et al., 1997). We have described a polymorphism (Met to Leu)
at the equivalent PrP site in elk, cervid codon 132 (O’Rourke et
al., 1998). In this study, we determined the PrP genotypes of
CWD-affected elk and of unaffected elk in several free-ranging
and captive populations to determine whether this codon
modulates susceptibility to CWD.
Methods
+ Animals. Tissues or peripheral blood samples were obtained from
captive and free-ranging Rocky Mountain elk from several locations and
were grouped by disease status, possible exposure to CWD and
geographical location (Table 1). The ages of CWD-affected elk ranged
from 17 months to 12 years. All unaffected farm-raised elk were adults
over 2 years of age when tested ; all free-ranging unaffected elk were over
15 months when sampled.
Group 1 included 20 CWD-affected elk born in free-ranging herds in
north-central Colorado (CO) or southern Wyoming (WY). Three of the
20 elk were born in or near Rocky Mountain National Park, CO, in June
1986, and transported at approximately 1 week of age to a research
facility. These three elk were diagnosed with CWD between May 1991
and February 1995 (Miller et al., 1998). The remaining 17 elk were free-
ranging animals from Larimer County, CO (nfl 12) and southern WY
(nfl 5).
Group 2 consisted of 88 healthy, hunter-harvested elk from Larimer
County, CO. The incidence of CWD in elk in this region, based on
examination of brain tissue from hunter-harvested elk, is less than 1% (M.
W. Miller, unpublished data). Group 3 consisted of healthy, hunter-
harvested elk collected near Jackson, WY, an area with no reported cases
of CWD. Brain tissue collected from elk in groups 2 and 3 showed neither
histological nor immunohistochemical evidence of CWD.
Group 4 included live, healthy elk from South Dakota (SD) that were
anaesthetized, radiocollared and released for a habitat evaluation project
by the US Department of Agriculture, Forest Service, Rocky Mountain
Research Station. Brain tissue will be collected if a radiocollared elk is
subsequently hunter-harvested. There are no reported cases of CWD in
free-ranging elk in SD. The elk in group 4 range the entire Black Hills
Table 1. PrP codon 132 genotypes of Rocky Mountain elk with CWD (groups 1 and 5)
and unaffected control herds
Group CWD status No. sampled 132Met/Met 132Met/Leu 132Leu/Leu
1 Positive 20 20 (100%) 0 0
2
3
4
5
6
7
8
Negative
88
55
42
60 (68%)
44 (80%)
35 (83%)
26 (30%)
11 (20%)
7 (17%)
2 (2%)
0
0
5 Positive 23 17 (74%) 6 (26%) 0
6
7
8
9
5
6
7
8
Negative
56
26
47
30
20 (36%)
13 (50%)
29 (62%)
29 (97%)
30 (54%)
12 (46%)
15 (32%)
1 (3%)
6 (10%)
1 (4%)
3 (6%)
0
region of SD and WY encompassing an area of 4500 square miles. This
area includes a privately owned game farm with a high incidence of CWD
(groups 5 and 6, as follows).
Groups 5 and 6 included farm-raised elk originating from a single SD
facility that houses elk in several different subpopulations, grouped by
sex, breeding status and age. CWD was diagnosed in an elk in this herd
in 1997. Examination of archived tissues suggests that a case occurred as
early as 1995. Forty-two cases have been confirmed subsequently. Frozen
tissues or blood samples collected at the time of euthanasia were
submitted from 23 elk subsequently diagnosed with CWD by histology
and}or immunohistochemistry (group 5). The youngest CWD-affected
animal was 17 months old when diagnosed ; all other CWD-positive elk
were 2 years of age or older. Blood samples were collected from 59 elk
(group 6) which had been penned with the CWD-affected elk. Group 6
elk are alive at the time of this writing or were healthy and free of
microscopic lesions and PrP-Sc immunostaining in brainstem tissue when
culled.
Blood samples were collected from healthy, live elk from a farm in
Minnesota with no history of CWD (group 7). These animals are
observed regularly and necropsies will be performed on elk that are culled
or die from injury or illness.
Samples were collected from 47 elk on a game farm in Montana (MT)
(group 8). A single animal originating from this herd was diagnosed with
CWD in 1998 after being housed in two facilities in other states between
1996 and 1998. CWD has not been diagnosed in any MT game farm
animals or MT wildlife at this time.
Group 9 consisted of 30 samples from farm-raised elk originating in
North Dakota and Nebraska and transported to a facility in SD. These
animals shared a short length (approximately 150 m) of fenceline with a
paddock housing 10 elk from the infected herd (groups 5 and 6). Elk were
housed in these adjoining paddocks for 90 days. A separation of groups
was re-established so that no fenceline contact was possible. Ninety days
of separation had occurred when a group 5 elk died from CWD. The
remaining nine elk from group 5 were removed from the facility. The 30
elk in group 9 remain in SD under quarantine with a mandatory CWD
laboratory diagnosis on all adult cervid deaths. No cases of CWD have
been diagnosed in this herd. Samples were collected from animals that are
alive at the time of this writing or were free of histological lesions and
PrP-Sc immunostaining when culled.
+ CWD diagnosis. Free-ranging affected elk were usually observed
by local residents who reported dead or sick animals. Clinical signs
included emaciation, loss of fear of humans, ataxia, inability to stand,
dehydration, excessive salivation, drooping of the head and ears and
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Fig. 1. (A) Western immunoblot, immunostained with polyclonal antisera to murine PrP-Sc, of proteinase-K-treated brain
homogenate from a CWD-affected elk (lane 1) showing proteinase-K-resistant glycoproteins characteristic of TSE infection.
Samples from a clinically normal elk (lane 2) processed under the same conditions show no immunoreactive proteins.
Molecular mass markers (lane 3) in kDa. (B) MAb F89/160.1.5 immunohistochemistry assay of brainstem of a CWD-affected
elk showing PrP-Sc antigen (red) accumulations within a brainstem nucleus.
rough dull haircoat. Captive elk were observed regularly by caretakers
familiar with the animals’ behaviour and euthanized when they exhibited
clinical signs of CWD (Miller et al., 1998). CWD was confirmed by
histopathological lesions, most notably spongiform encephalopathy
characterized by microcavitation, primarily of the grey matter, with
single or multiple intracytoplasmic vacuoles in neuronal perikarya and
neuronal degeneration (Spraker et al., 1997 ; Miller et al., 1998). Diagnosis
was confirmed by immunohistochemistry using MAb F89}160.1.5
(VMRD and ABR) (O’Rourke et al., 1998) (Fig. 1B) or rabbit polyclonal
anti-PrP antiserum R78295, provided by R. Rubenstein to the National
Veterinary Services Laboratories (Miller et al., 1994). When fresh brain
was available, tissues were examined for the presence of the disease-
associated isoform of PrP (PrP-Sc or scrapie-associated fibrils) via negative
stain electron microscopy (Guiroy et al., 1991) or by Western immunoblot
(Rubenstein et al., 1986) using a polyclonal anti-mouse (ME7) serum
provided by R. Rubenstein (Fig. 1A).
+ PrP sequence analysis. The amino acid sequence of the full-
length PrP gene product was deduced from the DNA sequence of PCR-
amplified genomic DNA, using PCR primers C.e.19fwd 5« ATT TTG
CAG ATA AGT CAT C 3« and C.e.778rev 5« AGA AGA TAA TGA
AAA CAG GAA G 3«. These primers flank the open reading frame and
are based on the DNA sequence of molecular clones of the mule deer PrP
gene (O’Rourke et al., 1998). This primer pair fails to amplify at least one
mule deer PrP allele (unpublished data) ; therefore, sequence analysis of
samples for this study was performed using internal primers spanning
codons 24–243 : forward primer C.e.bp70fwd 5« TGC AAG AAG CGA
CCA AAA CCT 3« and reverse primer C.e.bp729rev 5« CAC AGG AGG
GGA GGA GAA GAG GAT 3« in PCR buffer (Qiagen) using 2–5 mM
Mg+# (final concentration). Following a hot start (95 °C), samples were
amplified using 10 cycles of 95 °C for 30 s, 59 °C for 30 s, 72 °C for 45 s,
followed by 20 cycles of 95 °C for 30 s, 59 °C for 30 s, 72 °C for 60 s.
The amplified products were sequenced by dideoxynucleotide chain
termination by the Molecular Genetics Facility at the University of
Georgia using sequencing primers C.e.315fwd 5« CAG TAA ACC AAA
AAC CAA C 3« and C.e.583rev 5« TGG TGG TGA CTG TGT GTT
GCT TGA 3«, yielding sequence data for both strands between codons
112 and 180, for the sense strand only between codons 24 and 111, and
for the antisense strand from codon 181 to 243.
+ Statistical analysis. The v# test was used with the Yates correction
for continuity to compare genotype frequencies of animals with and
without CWD. For these analyses, animals homozygous for Met at
codon 132 were compared with the combined frequencies of animals
homozygous for Leu and heterozygous Met}Leu animals, in order to
eliminate most instances of analyses containing cells with no observations
or with more than 20% of the cells containing less than five expected
observations, situations where the v# test is considered unreliable. For
those comparisons where there were less than five expected observations
in one cell of a 2‹2 table even after combining Met}Leu and Leu}Leu
animals, genotype frequencies were compared by determining whether
or not there was overlap between the exact 95% confidence intervals of
both groups’ collapsed genotype frequencies based on the binomial
distribution. Genotype frequencies of CWD-affected elk born in the wild
in CO and WY (group 1) were compared to those of CWD-affected elk
of game farm origin (group 5). Genotype frequencies of the two CWD-
affected groups were compared separately to their appropriate control
groups. Group 1 elk, born wild in CO or WY, were compared to CWD-
unaffected elk from herds in CO, WY and SD (groups 2, 3 and 4 pooled).
Genotype frequencies of CWD-affected elk born and raised on game
farms (group 5) were compared to unaffected elk from the same facility
(group 6) and from pooled data from four game farms (groups 6, 7, 8
and 9). Genetic frequencies of CWD-affected elk in free-ranging and
game farm populations compared using Fisher’s exact test differed
significantly (Pfl 0–026).
Results
The PrP gene sequence of free-ranging Rocky Mountain elk
in this study was highly conserved, encoding a single amino
acid polymorphism (Met to Leu) at codon 132 and a silent
change (aag to aaa) at codon 104. In three geographically
distinct free-ranging populations (Table 1, groups 2, 3 and 4),
the mean frequencies of the codon 132 genotypes Met}Met,
CHGH
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Met}Leu and Leu}Leu were 0–751, 0–238 and 0–011 re-
spectively (Table 1). The frequencies of these three genotypes
did not differ significantly among the groups. Therefore, data
from groups 2, 3 and 4 were pooled for comparison with the
genotypes of free-ranging, CWD-affected elk. All free-ranging
elk with CWD (group 1, nfl 20) were genotype Met}Met at
codon 132. Thus, this genotype was significantly over-
represented in the CWD-affected elk compared to clinically
normal or CWD-negative free-ranging elk (P! 0–01, exact
binomial distribution).
Genotypic frequencies varied widely among the farm-
raised, unaffected elk (Table 1, groups 6, 7, 8, 9). Codon 132
genotype frequencies were significantly different among the
four captive elk herds sampled (v#fl 5–8, P! 0–05). Pairwise
testing showed that, with the exception of group 8, the
genotypes in each herd differed significantly from the
genotypes of the healthy free-ranging elk (pooled data from
groups 2, 3 and 4) (v#fl 5–8, P! 0–05). Therefore, the
genotype frequencies of farm-raised elk with CWD were
compared to non-affected elk from the same facility (group 5
vs group 6) rather than elk from the other game farms. The
frequency of Met}Met elk with CWD differed significantly
from that of non-affected elk from the same farm (v#fl 8, P!
0–01) (Table 1). Met}Met homozygosity was therefore
significantly over-represented in the CWD-affected farm-raised
elk at this facility.
Discussion
Conversion of PrP-C to PrP-Sc following exposure to
exogenous PrP-Sc is thought to initiate the TSE disease
process. The conversion mechanism is hypothesized to be a
two step nucleation–polymerization reaction in which the rate-
limiting step is the slow formation of the nucleus or seed
(Come et al., 1993). Nucleation rate is dependent on the
primary sequence of the monomer, homogeneity between
native PrP-C and exogenous PrP-Sc at critical residues, and the
concentration of heterogeneous peptides which favour dis-
aggregation of the nucleus (Come & Lansbury, 1994 ; Priola et
al., 1994). Human codon 129, encoding Met or Val, affects the
relative susceptibility, pathological lesion profile and clinical
course of several forms of CJD. Iatrogenic CJD, which probably
arises from exposure to tissues from humans with sporadic
CJD, occurs in all three codon 129 genetic groups. However,
individuals of either homozygous genotype are more sus-
ceptible than heterozygotes (Collinge et al., 1991). Sporadic
CJD, presumably arising from somatic mutation or low-level
exposure to the transmissible agent environmentally, occurs
most frequently but not exclusively in Met}Met129 homo-
zygotes (Palmer et al., 1991). nvCJD, which presumably arises
from exposure to PrP-Sc-contaminated products from cattle,
has been reported only in Met}Met129 homozygotes at this
time (Zeidler et al., 1997). The Rocky Mountain elk is the first
non-human species with a reported polymorphism at the
corresponding site (cervid codon 132) (O’Rourke et al., 1998).
In this study, we first analysed samples from free-ranging
elk with CWD. All 20 cases were homozygous for Met}
Met132, although the mean genotypic frequency of Met}
Met132 was 0–75 in the free-ranging populations. Twenty-
three cases of CWD in elk on a game farm in SD provided a
second sample group. A total of 74% of the captive CWD-
affected elk sampled were homozygous for Met}Met132
although only 47% of the sampled elk from this herd were
Met}Met132 homozygotes. Taken together, these data
suggest thatMet}Met132 homozygosity predisposes exposed
elk to CWD.
CWD was diagnosed in Met}Leu132 heterozygotes in the
game farm population but not in free-ranging elk. This
observation may be an artefact of small sample size of free-
ranging CWD-affected elk and the low frequency of the
132Leu allele in free-ranging elk. Alternatively, this difference
may reflect varying routes or doses of the transmissible agent
under the game farm husbandry conditions or the presence of
a novel CWD strain. Biochemical profiles of PrP-Sc from
different populations and different genetic groups will provide
additional insight into the range of CWD disorders in elk. The
relationship between heterozygosity and incubation time in
natural disease cannot be determined in CWD-infected herds
because the time of infection is not known. However, two of
the CWD-affected Met}Leu elk were diagnosed at age 2 years,
indicating that heterozygosity is not invariably associated
with prolonged incubation time.
The absence of CWD in the Leu}Leu132 elk population is
of interest. Homozygosity for PrP Ala136 is associated with
resistance to strain A scrapie in sheep (Goldmann et al., 1994a)
and a single copy of the ovine PrP allele encoding Arg171 is
sufficient to protect most sheep from strain C scrapie
(Goldmann et al., 1994b). Insufficient numbers of elk with the
Leu}Leu genotype were available to allow evaluation of their
relative susceptibility to CWD. Extended observations on the
surviving elk from the CWD-affected herd and experimental
infection of Leu}Leu132 elk with infectious material from
Met}Leu132 elk will be necessary to determine the relative
resistance of Leu}Leu132 elk to CWD.
Selective breeding for TSE resistance is a valuable adjunct
to epidemiology and diagnostic testing in control of sheep
scrapie (Dawson et al., 1998) if the scrapie strains endemic in
the population are known. Our data suggest that large
proportions of many free-ranging and farmed Rocky Mountain
elk populations are susceptible to CWD. The interaction of PrP
genetic polymorphisms and CWD strain types in clinical
disease progression, relative susceptibility, transmission
efficiency and incubation time in elk warrants further investi-
gation.
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